within Pharmacolibrary.Drugs.N_NervousSystem.N01B_AnestheticsLocal.N01BB51_BupivacaineCombinations;

model BupivacaineCombinations
  extends Pharmacolibrary.Drugs.ATC.N.N01BB51;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>N01BB51</td></tr><td>route:</td><td>epidural</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Bupivacaine is a long-acting local anesthetic belonging to the amide-type class, often used for regional anesthesia, including epidural, spinal, and peripheral nerve blocks. It acts by blocking sodium channels, thereby inhibiting nerve impulse propagation. As a combination product (ATC N01BB51), it is typically formulated with other anesthetics or analgesics for surgical anesthesia and pain management. Bupivacaine is approved and widely used in various clinical settings today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult patients, mixed sex, receiving epidural administration of bupivacaine as part of a combination preparation.</p><h4>References</h4><ol><li><p>Veering, BT, et al., &amp; Van Kleef, JW (2002). Pharmacokinetics of bupivacaine during postoperative epidural infusion: enantioselectivity and role of protein binding. <i>Anesthesiology</i> 96(5) 1062–1069. DOI:<a href=&quot;https://doi.org/10.1097/00000542-200205000-00006&quot;>10.1097/00000542-200205000-00006</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11981143/&quot;>https://pubmed.ncbi.nlm.nih.gov/11981143</a></p></li><li><p>Hansdóttir, V, et al., &amp; Nordberg, G (1996). The pharmacokinetics of continuous epidural sufentanil and bupivacaine infusion after thoracotomy. <i>Anesthesia and analgesia</i> 83(2) 401–406. DOI:<a href=&quot;https://doi.org/10.1097/00000539-199608000-00034&quot;>10.1097/00000539-199608000-00034</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8694326/&quot;>https://pubmed.ncbi.nlm.nih.gov/8694326</a></p></li><li><p>Atkinson Ralls, L, et al., &amp; Carvalho, B (2011). Prior epidural lidocaine alters the pharmacokinetics and drug effects of extended-release epidural morphine (DepoDur®) after cesarean delivery. <i>Anesthesia and analgesia</i> 113(2) 251–258. DOI:<a href=&quot;https://doi.org/10.1213/ANE.0b013e318222f59c&quot;>10.1213/ANE.0b013e318222f59c</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21642610/&quot;>https://pubmed.ncbi.nlm.nih.gov/21642610</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end BupivacaineCombinations;
